Milestone Scientific announced a conference call on November 13, 2026, to discuss its third quarter financial results ending September 30, 2026. The call will cover the company's financial performance, corporate progress, and other developments. Investors can join via phone or webcast, with a replay available until November 27, 2026. Milestone Scientific specializes in computerized drug delivery systems designed to improve injection precision and patient comfort.
Milestone Scientific's upcoming Q3 2026 financial results call is noted here for context. For readers following the health sector, 87 of 150 US health stocks rose while 61 fell on Pluang. Notable movers include Summit Therapeutics Inc at USD 16.71 with a -6.28% change, Twist Bioscience Corp at USD 124.10 down 6.08%, and Revolution Medicines Inc. at USD 181.41 down 6.03%, as of Nov 12, 2026 04:11 WIB.
Ashland Inc.'s board of directors declared a quarterly cash dividend of $0.42 per share, payable on December 15, 2026, to shareholders of record as of December 1, 2026. This dividend reflects the company's ongoing commitment to returning value to sha...
AeroVironment secured a $405 million international order for its LOCUST X3 high-energy laser weapon systems, enhancing counter-drone defense capabilities in the Middle East amid rising regional security threats. Following the announcement, AeroVironm...
Vestas Wind Systems reported Q3 2026 earnings per share of $0.13 and revenue of $6.34 billion, both below analyst expectations. The company's profit was impacted by weak sales volume and a broken turbine blade. Following the earnings miss, Vestas' sh...
The global beverage market is projected to grow from $2.03 trillion in 2026 to $2.78 trillion by 2032, at a CAGR of 5.35%. Growth is fueled by rising demand for nonalcoholic and functional beverages, convenience packaging, and premium products for sp...
DelveInsight's 2026 report reveals more than 200 GLP-1 receptor agonists and incretin-based therapies are in development by over 180 companies, targeting conditions like type 2 diabetes, obesity, and related metabolic disorders. Key players such as E...
